Iclusig
Ended Awarded Last action
- Contract number
- 36C26024F0632
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $27,913
Award facts
- Contract value 100% obligated
- $27,913.44 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Earth City, MO 63045, USA
Award details come from SAM.gov/FPDS.
About this award
This is a delivery order award to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products, under the company's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs. The contract, valued at $27,913.44, is for the supply of the oncology medication ICLUSIG (ponatinib) to the U.S. Department of Veterans Affairs (VA).
The award is part of a larger Blanket Purchase Agreement (BPA) between Takeda and the VA National Acquisition Center, valued at over $13 million, for the supply of ICLUSIG products to multiple VA medical facilities nationwide. This single-award BPA was initially awarded in October 2019 and is set to run through October 2024.
The contract has a firm-fixed-price pricing type and does not have a set-aside designation, indicating Takeda's status as a large, foreign-owned business. As the primary funding agency, the VA is supporting the healthcare needs of veterans through this contract for critical specialty pharmaceuticals.
Quick answers
Who was awarded contract 36C26024F0632?
36C26024F0632 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on September 20, 2024.
How much is contract 36C26024F0632 worth?
The government has obligated $27,913 on 36C26024F0632.
Is contract 36C26024F0632 an order under another contract?
Yes. 36C26024F0632 is a delivery order under 36F79718D0586, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0632 competed?
The extent of competition for 36C26024F0632 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award